Evgen Pharma Share Price (EVG)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Evgen Pharma	LSE:EVG	London	Ordinary Share	GB00BSVYN304	ORD 0.25P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+0.00p	+0.00%	18.00p	133	08:00:00

Bid Price		Offer Price	High Price	Low Price	Open Price
17.50p		18.50p	18.00p	18.00p	18.00p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology		-3.03	-3.28		16.8

Related Shares
GlaxoSmithKline (GSK), AstraZeneca (AZN), Geiger Count. S (GCS), Port Erin (PEBI)

Evgen Pharma (EVG) Latest News

Evgen Pharma News

Date	Time	Source	Headline
26/7/2018	15:22	UKREG	Evgen Pharma PLC Result of AGM
26/7/2018	12:54	ALNC	Evgen Pharma Expects Final Results From Clinical Trials At End Of Year
26/7/2018	07:58	ALNCF	Alliance News Flash Headline
26/7/2018	07:02	UKREG	Evgen Pharma PLC AGM Statement
25/7/2018	13:31	ALNC	Evgen Pharma Metastatic Breast Cancer Trial Ends Patient Recruitment
25/7/2018	07:00	UKREG	Evgen Pharma PLC Final Patient Recruited in STEM Phase IIa Trial
10/7/2018	11:00	UKREG	Evgen Pharma PLC Grant of share options, issue of equity and TVR
21/6/2018	12:30	UKREG	Evgen Pharma PLC Posting of Annual Report and AGM Notice
13/6/2018	10:46	ALNC	Evgen Pharma Annual Loss Narrows As It Continues Phase II Trials
13/6/2018	07:00	UKREG	Evgen Pharma PLC Full Year Results

More Evgen Pharma News

Evgen Pharma Takeover Rumours

Evgen Pharma (EVG) Share Charts

1 Year Evgen Pharma Chart

1 Month Evgen Pharma Chart

Intraday Evgen Pharma Chart

Evgen Pharma (EVG) Discussions and Chat

Evgen Pharma Forums and Chat

Date	Time	Title	Posts
13/8/2018	11:55	Evgen Pharma: Developing Sulforaphane to treat Stroke, MS and Cancer	643
17/6/2018	15:42	Interview and Q&A with Evgen Pharma	2
26/6/2017	07:38	Evgen Pharma Plc Investor Presentation	-
13/6/2017	09:45	Evgen Pharma Interview	-
29/11/2016	08:27	Evgen Pharma (EVG) chief executive Stephen Franklin	39

Add a New Thread

Evgen Pharma (EVG) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
08:04:02	18.08	133	24.04	O
2018-08-15 15:20:07	17.75	1,254	222.59	O
2018-08-15 15:04:07	17.75	15,000	2,662.50	O

View all Evgen Pharma trades in real-time

Evgen Pharma (EVG) Top Chat Posts

Date	Subject
16/8/2018 09:20	Evgen Pharma Daily Update: Evgen Pharma is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker EVG. The last closing price for Evgen Pharma was 18p. Evgen Pharma has a 4 week average price of 16.50p and a 12 week average price of 16.50p. The 1 year high share price is 29.38p while the 1 year low share price is currently 12p. There are currently 93,356,858 shares in issue and the average daily traded volume is 58,910 shares. The market capitalisation of Evgen Pharma is £16,804,234.44. Read Full Thread Reply
14/6/2018 10:13	teddy boy1: Yet another tree shake this morning.On the basis of todays very thin trading was this justified? Absolutely not! I will say it one more time (at least) -this share is being well and truly "worked" and until such times as buyers return in force these people have the upper hand! How low can it go? As low as they want to take it ! UNLESS - we stand up and fight back! This is becoming almost too farcical for words _ how can a company with such a promising update be marked down so savagely? Its just as I said yesterday - if there is a TINY shadow of doubt about a small companys future or results(especially one where the shares are very tightly held) these people will work on this by stepping down the price so that some investors will read something into this (when there is nothing untoward) and sell their shares and this in turn sets of a series of buys- this can then be repeated again and again, almost on a daily basis if they so desire ! The result- we end up with a ropey share price which produces a valuation which bears no relationship to the worth of that company! Are we just going to stand back and let it happen? ,content in the knowledge that once in a while we will be allowed one "good " day when they dispose of their accumulated shares, by stepping up the price to try and fool us that something good is afoot and all of a sudden after days of hardly any buying, people investors pile in again and try to fool themselves into coming up with "reasons" for the rise. LETS FIGHT, FIGHT AND FIGHT ! Read Full Thread Follow Reply
13/6/2018 12:25	teddy boy1: Have just checked on todays trading and see that BUYS outweigh sells by half as much again and yet the share price is way down on the day.! How can this be right (morally) Can someone please explain the logic behind all this ?( apart from share price manipulation of the first degree) Read Full Thread Follow Reply
13/6/2018 12:14	teddy boy1: There should be a law against what has happened this morning ;the way the share price was systematically taken down to encourage more sales.This share is definitely being "worked " and the bottom line is that all the shorters and the market makers have made themselves a shed load of money over the past 3 days- and this is on a GOOD trial update ! Think of what would have happened if the news had been bad! On second thoughts the share price would not have been too much different ,left to its own devices. Anyhow this is AIM , and this is how things are ! Perhaps companys such as EVGEN and IDP with very tightly held shares should be avoided like the plague as they are prime candidates for manipulation . With such companys;until they have proved themselves 100 per cent, the seeds of doubt will be sown and before we know where we are the share price has been worked down until the share price bears no resemblance to its true value. This is a real pity as I have not read anything myself which would encourage me to dispose of my shares as, as far as I am concerned ,Evgen Pharma has a very bright future .However ,it could still be many months/years before we are allowed a TRUE share price which values the company for what it is worth and not what some individuals CAUSE it to be, in the quest to make some easy money for themselves, over and over again! Anyone else agree with my sentiments? Read Full Thread Follow Reply
12/6/2018 16:14	teddy boy1: The fact that the share price jumped up by 8 per cent as soon as the trial update was announced says it all as far as I am concerned. ! It was then decided that the share price HAD to come down by the market makers (and probably some shorters as well!) and this is what has been happening but as soon as they feel that they have taken it as low as it will go ,expect to see a big reversal! You heard it here first! Read Full Thread Follow Reply
12/6/2018 11:48	teddy boy1: Still a decent amount of buying going on so it seems that there are many who have "kept the faith", which in the light of the trial update is not too surprising. It is clear to me that the share price was stepped down yesterday by the market makers in order to try and sow doubt so that they could accumulate some more of these tightly held shares. Within the next day or two the process will be reversed. The share price will be stepped up at the beginning of the day and this will attract buyers. How do I know.?- because this process is being repeated again and again on shares such as this.! The bottom line is that the update reads very well and gives encouragement to the company to plough ahead to demonstrate to all concerned that they have a winner on their hands.This is ,of course , assuming that they do not get taken out before very long by one of the big pharmas who will be able to see that this treatment definitely "has legs" and consequently could, in time, be a useful and profitable addition to their portfolio WATCH THIS SPACE! Read Full Thread Follow Reply
11/6/2018 19:57	teddy boy1: It is pleasing to see that Northland Capital having seen the trial update,are still of the opinion that the share price target should remain unchanged at 113P. In my opinion there has been a certain amount of share price manipulation to-day as there has been more buying than selling. If past experience is anything to go by, I will be very surprised if the price does not show a nice "correction" tomorrow. Things are still on course for Evgen although it will be another 6 months before this has been one hundred per cent proved. In the meantime I am still more that happy to have this share in my portfolio! Read Full Thread Follow Reply
09/6/2018 10:29	teddy boy1: I personally can still see quite a bit more mileage in the share price. As more and more perspective investors are becoming aware of "the story" behind Evgen Pharma and realise that ,although not without risk, it has its attractions, I can see more and more demand for these tightly held shares.Also, as they will want to purchase shares before the results and update are announced we may not have to wait too long for the next share uplift.! Read Full Thread Follow Reply
04/6/2018 14:35	teddy boy1: A penny a day increase in the share price does not seem too ambitious to me. !The potential is enormous. I can see the share price ending the day quite a bit higher that it currently stands! Read Full Thread Follow Reply
04/6/2018 14:25	teddy boy1: If "we get a sniff" that things are going well in the update coming shortly (interim) the share price could go into orbit is there was only a small free float. Judging by the brokers target price they too see a lot of potential here. The company has made it easy for anyone wanting to research Evgen Pharma as all the tests ,trails and results are very well documented. This is definitely one to watch but do not leave it too long as time is running out for anyone who wants a piece of the action. DYOR Read Full Thread Follow Reply
03/5/2018 15:04	bernymadoff: Only idiots look at the rise and fall of a share price to determine whether they should invest and at what price. It wasn't long ago that institutions were paying 37p on IPO to get exposure to the drugs EVG are testing. Since then many of them have continued to buy and they currently hold 55% or so of the whole company. Institutional investment is one of the major ingredients I look for when deciding to invest anywhere. It gives you a level of confidence knowing that experts have evaluated the company to a degree that lay people could not achieve. Big plus there. Then there is the performance of the company. To date EVG have not put a foot wrong and all their drug trials have exceeded market expectations. Yet the market has not assigned any value to the progress the company has made since IPO in October 2015. Like many other pre-revenue AIM companies with great potential it has been at the mercy of the spivs in the city who have manipulated the share price down so that they can screw the company in the knowledge that it is dependent on placings to see it through to commercialisation. There is a wealth of information out there showing just how disconnected the share price is to the actual potential of EVG. For me that's where the opportunity lies. The greater the disconnect the greater the correction (in fact in these cases the correction often overshoots to the overvalued side). The other big thing the company has going for it is that it is funded through to the end of the year by which point it may well have landed a licensing or JV deal if the results due this quarter and then again at the end of the year are any good. Certainly the CEO has been dropping hints to that effect in recent rns'. You can choose to play the swings or you can hold for the big prize that the evidence suggests is now within grasp. Read Full Thread Follow Reply

Evgen Pharma share price data is direct from the London Stock Exchange

add chat code

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:40 V: D:20180816 12:21:29